Neuroguard IEP 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection
Contego Medical, Inc. · Decision date Oct 11, 2024
What did the FDA approve?
FDA records P240009 as an original PMA application. The recorded decision is approval, dated Oct 11, 2024.
FDA approval order statement
This Neuroguard IEP 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection is indicated for improving the carotid luminal diameter in subjects at high risk for adverse events from carotid endarterectomy who require carotid revascularization and meet the criteria outlined below: Patients with symptomatic stenosis of the common or internal carotid artery with >=50% as determined by angiography using NASCET methodology, or Patients with asymptomatic stenosis of the common or internal carotid artery with >=80% as determined by angiography using NASCET methodology; Patients with reference vessel diameters 4.0 8.0 mm. This device is also indicated for post-dilation of the stent component with simultaneous capture and removal of embolic material. The Neuroguard IEP System should always be used in conjunction with an available primary distal embolic protection device as described in the IFU.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 11, 2024
Regulatory record facts
- Identifier
- P240009
- Regulatory pathway
- Premarket approval application
- Applicant
- Contego Medical, Inc.
- Product code
- NIM
- Decision code
- APPR
- Decision date
- Oct 11, 2024
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stent, carotid.
- Applicant
- Contego Medical, Inc.
- Product code
- NIM
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P240009 received
Application receipt date recorded by FDA.
P240009 · FDA decision
APPR
P240009/S006 · Related supplement
Neuroguard IEP 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection
Timeline entries are records held by MedtechLedger for P240009. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P240009
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Contego Medical, Inc. | PMA supplement | Nov 4, 2026 | FDA |
Explore the linked device profile
Other records with product code NIM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMSP060001/S060 | Medtronic Vascular, Inc. | PMA supplement | Nov 5, 2026 | FDA |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA approval | Jan 24, 2007 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Contego Medical, Inc.
- Headquarters
- Not reported
- Brand website
- contegomedical.com
- FDA applicant address
- 3801 Lake Boone Trl., Suite 100, Raleigh, NC, 27607
Sources and methodology
- Original FDA record: P240009
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

